Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Sham Innovation Santé

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 22
Average round size
info
The average size of a deal this fund participated in
$21M
Portfolio companies 13
Rounds per year 0.23
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.41
Exits 2
Key employees Soon

Areas of investment

  • Medical
  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Medical Device
Summary

Among the most popular portfolio startups of the fund, we may highlight CarThera, Horama, Antabio. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most popular fund investment industries, there are Health Care, Genetics.

The higher amount of exits for fund were in 2017. The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is generally included in less than 2 deals every year.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Sham Innovation Santu00e9, startups are often financed by Octalfa, Bpifrance, Wellcome Trust. The meaningful sponsors for the fund in investment in the same round are Octalfa, Pontifax, Omnes Capital. In the next rounds fund is usually obtained by Octalfa, V-Bio Ventures, Sofimac Partners.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Sham Innovation Santé:
Typical Co-investors
Sham Innovation Santé is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Sham Innovation Santé:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
ActoMezz France, Ile-de-France, Paris
Business Angels Club Berlin Berlin, Berlin, Germany
Forebright Capital China, Guangdong, Shenzhen
Haisco China, Liaoning, Wenxiang
Huck Capital California, San Francisco, United States
HYGE Interface Japan, Tokyo
KOLBE -
Matomy Israel, Tel Aviv, Tel Aviv District
Particle -
Pentair Richmond upon Thames, Twickenham, United Kingdom
Saudi Aramco Ash Sharqiyah, Dhahran, Saudi Arabia
Seven Peaks Ventures Bend, Oregon, United States
Spearhead California, San Francisco, United States
Taiya Dingfu China, Fujian, Xiamen
Taofen8.com China, Hangzhou, Zhejiang
Tehua Investment Beijing, Beijing, China
Xinhu Zhongbao Co Ltd China, Hangzhou, Zhejiang
Xinyi Fund China, Hongkou District

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Therapixel

Artificial Intelligence
Health Diagnostics
Medical Device
Software
$17M12 May 2022 Nice, Provence-Alpes-Côte d'Azur, France

Cairdac

Manufacturing
Medical Device
$20M31 Mar 2022 Antony, Ile-de-France, France

Amolyt Pharma

Health Care
Medical
Therapeutics
$80M16 Sep 2021 Écully, Rhone-Alpes, France

Coave Therapeutics

Biotechnology
$38M21 Jul 2021 Bretagne, Brittany, France

Mablink Bioscience

Biotechnology
Pharmaceutical
$4M27 Apr 2021 Lyon, Rhone-Alpes, France

AbolerIS Pharma

Biotechnology
$2M04 Nov 2020 Nantes, Pays de la Loire, France

Alizé Pharma

Biotechnology
Health Care
Medical
Pharmaceutical
Wellness
$79M31 Jul 2019 France, Auvergne-Rhône-Alpes, France

CarThera

Biotechnology
Health Care
Medical Device
Therapeutics
$10M12 Dec 2018 France, Ile-de-France

Antabio

Biotechnology
Life Science
Medical Device
$6M12 Jul 2018 France, Auvergne-Rhône-Alpes
News
Mablink Bioscience Raises €4M in Seed Funding

– Mablink Bioscience is a Lyon, France-based company developing antibody-drug conjugates (ADC).
– The company raised €4M in a seed financing round.
Elaia Partners led the round with participation from Pertinence Invest 2 (Sofimac Innovation advised by Mérieux Equity Partners), Sham Innovation Santé (advised by Turenne Capital), Fondation Fournier-Majoie, Simba Santé (Angelor) and Crédit Agricole Création.
– The new investment will be used to move forward its ADC pipeline.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Sham Innovation Santé?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 22
Average round size 21M
Rounds per year 0.23
Peak activity year 2021
Lead investments 0
Follow on index 0.41
Exits 2
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Therapixel

Artificial Intelligence
Health Diagnostics
Medical Device
Software
$17M12 May 2022 Nice, Provence-Alpes-Côte d'Azur, France

Cairdac

Manufacturing
Medical Device
$20M31 Mar 2022 Antony, Ile-de-France, France

Amolyt Pharma

Health Care
Medical
Therapeutics
$80M16 Sep 2021 Écully, Rhone-Alpes, France

Coave Therapeutics

Biotechnology
$38M21 Jul 2021 Bretagne, Brittany, France

Mablink Bioscience

Biotechnology
Pharmaceutical
$4M27 Apr 2021 Lyon, Rhone-Alpes, France

AbolerIS Pharma

Biotechnology
$2M04 Nov 2020 Nantes, Pays de la Loire, France

Alizé Pharma

Biotechnology
Health Care
Medical
Pharmaceutical
Wellness
$79M31 Jul 2019 France, Auvergne-Rhône-Alpes, France

CarThera

Biotechnology
Health Care
Medical Device
Therapeutics
$10M12 Dec 2018 France, Ile-de-France

Antabio

Biotechnology
Life Science
Medical Device
$6M12 Jul 2018 France, Auvergne-Rhône-Alpes
Crunchbase icon

Content report

The following text will be sent to our editors: